|
| |
SCIENTIFIC PROGRAM
| FRIDAY,
MARCH 9, 2001 |
| 08:00-08:10 |
WELCOME |
| 08:00
|
WELCOME AND
GREETINGS
D.
Harats, Tel Hashomer, Israel
Y. Shoenfeld, Tel Hashomer, Israel
G. Wick, Innsbruck, Austria |
| 08:10
- 10:00 |
INFLAMMATION
AND ATHEROSCLEROSIS
Chairpersons:
P. Libby, Boston, MA, USA
S. Calandra, Modena, Italy |
| 08:10 |
INFLAMMATORY
PROCESSES IN ATHEROSCLEROSIS
P. Libby, Boston, MA, USA |
| 08:40 |
MODULATION
OF C-REACTIVE PROTEIN-MEDIATED MCP-1 INDUCTION IN HUMAN ENDOTHELIAL
CELLS BY ANTI-ATHEROSCLEROSIS DRUGS
E.T.H. Yeh, V.
Pasceri, J. Chang, J.T. Willerson, USA |
| 09:00 |
INFLAMMATION
AS A RISK FACTOR FOR VASCULAR PROLIFERATIVE DISEASE OF THE LOWER LIMBS
T. Vainas, H.A.J.M. Kurvers, M. van Dieijen, R.Th.J. Welten, L. van den Akker, J.H.M.
Tordoir, G.W. Schurink, P.J.E.H.M. Kitslaar, C.A. Bruggeman, Maastricht,
The Netherlands |
| 09:15 |
APOLIPOPROTEIN
E HAS A NEGATIVE AND INDEPENDENT INFLUENCE ON C-REACTIVE PROTEIN (CRP)
CONCENTRATION IN OBESE ADULTS
J.M. Bard, K. Bach-Ngohou, H. Nazih, F. Nazih-Sanderson, Y. Zaier, D. Le Carrer, M.
Krempf, Nantes, France |
| 09:30 |
A
NEWLY DISCOVERED LANGERHANS CELL-LIKE NETWORK OF DENDRITIC CELLS IN THE
NORMAL INTIMA
OF HEALTHY YOUNG INDIVIDUALS
G. Millonig, D.
Hoefer, G. Wick, Innsbruck, Austria |
| 09:40 |
COMPLEMENT
ACTIVATING ANTIBODIES AGAINST THE 60 kD HEAT SHOCK PROTEINS AS A NEW
FAMILY RISK FACTOR OF CORONARY HEART DISEASE
L. Cervenak, T. Szamosi, A. Veres, Z. Prohaszka, M. Alblonczy, M. Singh,
L. Romics, G. Fusst, Budapest, Hungary, Germany |
| 09:50 |
PRESENCE OF
TYPE 1 NATURAL KILLER (NK T) CELLS IN ATHEROSCLEROTIC PLAQUES
N. Pejnovic, H. Hamilton, W.L. Chan, London, UK |
| 10:00 |
Coffee
Break and Poster Visit |
| 10:30
- 12:00 |
EDUCATIONAL WORKSHOP: ANTI-INFLAMMATORY PROPERTIES OF HYPOLIPIDEMIC
DRUGS
(Sponsored by Neopharm Ltd., Israel)
Chairperson: P. Libby, Boston, MA, USA |
| 10:30 |
ANTI-INFLAMMATORY
EFFECTS OF STATINS AND PPAR AGONISTS
P. Libby, Boston, MA, USA |
| 11:00 |
STATINS AS
A NEWLY RECOGNIZED TYPE OF IMMUNOMODULATOR
F. Mach, Geneva, Switzerland |
| 11:30 |
ANTI-OXIDANTS
AND MODULATION OF ATHEROSCLEROSIS
J.L. Witztum, La Jolla, San Diego, CA, USA |
| 12:00 |
Lunch Break
and Poster Visit |
| 13:30
- 15:00 |
IMMUNE
MECHANISM IN ATHEROSCLEROSIS (I)
Chairpersons:
D. Harats, Tel Hashomer, Israel
J.B. Peter, USA |
| 13:30 |
PUTATIVE
AUTOANTIGENS IN ATHEROSCLEROSIS
D. Harats, Tel Hashomer, Israel |
| 14:00 |
IMMUNOLOGICAL
FACTORS IN EARLY HUMAN HYPERTENSION AND ATHEROSCLEROSIS
J. Frostegard, Y. Huang, G. Fei, U. De Faire, Stockholm, Sweden |
| 14:10 |
LACK OF
ASSOCIATION BETWEEN HIGH LEVELS OF ANTIBODIES AGAINST 60 kD HEAT SHOCK
PROTEINS AND INFECTION WITH C. PNEUMONIAE AND H. PYLORI IN PATIENTS WITH
CORONARY HEART DISEASE
Z. Prohaszka, V. Endresz, J. Duba, B. Fekete, I. Karadi, L. Romics, M.
Singh, E. Gonczol, G. Fust, Budapest, Hungary, Germany |
| 14:20 |
AUTOANTIBODY-DEPENDENT
UPTAKE OF OXIDIZED LDL BY MACROPHAGES IS MEDIATED BY OXIDIZED LIPID
LIGANDS
K. Kobayashi, E. Matsuura, Q. Liu, K. Kaihara, J. Inagaki, J. Kasahara,
T. Yasuda, T. Koike, Okayama, Japan |
| 14:30 |
DETECTION
OF ADAMS AND ADAMTSS IN ATHEROSCLEROSIS
E. Oviedo-Orta, S. George, A. Chase, A. Newby, Bristol, UK |
| 14:40 |
ATORVASTATIN
REDUCES FIBRINOGEN LEVELS IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
D. Gavish, E. Leibovitz, N. Hazanov, A. Freiman, R. Zimlichman, Holon,
Israel |
| 14:50 |
AUTOANTIBODIES
TO OXIDIZED PALMITOYL ARACHIDONOYL PHOSPHOCHOLINE IN ATHEROSCLEROSIS
R. Wu, G.Q. Shen, M. Matnaik, J.B. Peter, Santa Monica, CA, USA |
| 15:00 |
Coffee
Break and Poster Visit |
| 15:30
- 17:30 |
OXIDATIVE MECHANISM IN ATHEROGENESIS
Chairpersons:
J.L. Witztum, San Diego, CA, USA
T. Koike, Sapporo, Japan
T. Chajek-Shaul, Jerusalem, Israel |
| 15:30 |
INTRODUCTION
T. Koike, Sapporo, Japan |
| 15:40 |
IMMUNE
RESPONSE TO OXIDATION-SPECIFIC NEO SELF-DETERMINANTS
J.L. Witztum, San Diego, CA, USA |
| 16:10 |
OXIDIZED
AUTOANTIGENS IN ATHEROSCLEROSIS
E. Matsuura, Okayama, Japan |
| 16:40 |
AUTOANTIBODIES
AGAINST OXIDIZED LDL
O. Narvanen, S. Yla-Herttuala, Kuopio, Finland |
| 17:00 |
HIGH
CORRELATION BETWEEN LP(A) LEVELS AND THE PRESENCE OF AN OXIDATION
SPECIFIC EPITOPE ON LDL IN HUMAN PLASMA
C. Bergmark, S. Horkko, K. Kuroe, J.L. Witztum, Stockholm, Sweden, USA |
| 17:10 |
CORONARY
ARTERY DISEASE BUT NOT CORONARY CALCIFICATION IS ASSOCIATED WITH
ELEVATED LEVELS OF CARDIOLIPIN, beta-2-GLYCOPROTEIN-I, AND OXIDIZED-LDL
ANTIBODIES
Y. Sherer, A. Tenenbaum, M. Blank, J. Shemesh, S. Praprotnik, E.Z.
Fishman, D. Harats, J. George, Y. Levy, J.B. Peter, M. Motro, Y.
Shoenfeld, Tel Hashomer, Israel, USA |
| 17:20 |
ANTIBODIES
AGAINST LYSOPHOSPHATIDYLCHOLINE, PHOSPHATIDYLCHOLINE AND CARDIOLIPIN IN
PATIENTS
WITH HYPERLIPOPROTEINEMIAS
V. Tesar, L. Fialova, R. Ceska, L. Mikulikova, I. Malbohan, T. Zima,
Prague, Czech Republic |
| 18:00 |
Welcome
Reception |
| 19:30-20:30 |
THE
SHLOMO EISENBERG MEMORIAL LECTURE
Chairpersons:
Y. Stein, Jerusalem, Israel
D. Harats, Tel Hashomer, Israel |
| 19:30 |
INTRODUCTION
Y. Stein,
Jerusalem, Israel, D. Harats, Tel Hashomer, Israel
|
| 19:40 |
TRANSGENIC
MOUSE MODEL OF ATHEROSCLEROSIS
J. Breslow, New York, USA |
|
